Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Truist Securities Maintains Hold on National Health Investors, Raises Price Target to $65

Author: Benzinga Newsdesk | June 26, 2024 10:47am
Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Hold and raises the price target from $58 to $65.

Posted In: NHI